AAAAAA
Results:
1-15
|
Results: 15
Authors:
Krause, PR
Citation: Pr. Krause, Adventitious agents and vaccines, EM INFECT D, 7(3), 2001, pp. 562-562
Authors:
Strickler, HD
Goedert, JJ
Butel, JS
Daniel, R
Freymuth, F
Gibbs, A
Griffiths, DJ
Jablons, D
Jasani, B
Jones, C
Lednicky, JA
Miller, CW
Radu, C
Richards, WG
Shah, KV
You, L
Corson, JM
Gerwin, B
Harris, C
Sugarbaker, DJ
Egan, W
Lewis, AM
Krause, PR
Peden, K
Levine, AS
Melnick, S
Cosentino, M
da Costa, M
Devairrakam, V
Ji, J
Palefsky, J
Rasmussen, L
Shea, K
Wacholder, S
Waters, D
Wright, T
Citation: Hd. Strickler et al., A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens, CANC EPID B, 10(5), 2001, pp. 523-532
Authors:
Krause, PR
Klinman, DM
Citation: Pr. Krause et Dm. Klinman, Disseminated rashes and varicella vaccine, PEDIAT INF, 20(4), 2001, pp. 467-468
Authors:
Wang, KN
Pesnicak, L
Guancial, E
Krause, PR
Straus, SE
Citation: Kn. Wang et al., The 2.2-kilobase latency-associated transcript of herpes simplex virus type 2 does not modulate viral replication, reactivation, or establishment of latency in transgenic mice, J VIROLOGY, 75(17), 2001, pp. 8166-8172
Authors:
Krause, PR
Klinman, DM
Citation: Pr. Krause et Dm. Klinman, Varicella vaccination: Evidence for frequent reactivation of the vaccine strain in healthy children, NAT MED, 6(4), 2000, pp. 451-454
Authors:
Krause, PR
Klinman, DM
Citation: Pr. Krause et Dm. Klinman, Varicella vaccine revisited - Reply, NAT MED, 6(12), 2000, pp. 1300-1300
Authors:
Sierra-Honigmann, A
Krause, PR
Citation: A. Sierra-honigmann et Pr. Krause, Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA, BIOLOGICALS, 28(1), 2000, pp. 1-4
Authors:
Wise, RP
Salive, ME
Braun, MM
Mootrey, GT
Seward, JF
Rider, LG
Krause, PR
Citation: Rp. Wise et al., Postlicensure safety surveillance for varicella vaccine, J AM MED A, 284(10), 2000, pp. 1271-1279
Authors:
Loparev, VN
Argaw, T
Krause, PR
Takayama, M
Schmid, DS
Citation: Vn. Loparev et al., Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR, J CLIN MICR, 38(9), 2000, pp. 3156-3160
Authors:
Loparev, VN
McCaustland, K
Holloway, BP
Krause, PR
Takayama, M
Schmid, DS
Citation: Vn. Loparev et al., Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes, J CLIN MICR, 38(12), 2000, pp. 4315-4319
Authors:
Argaw, T
Cohen, JI
Klutch, M
Lekstrom, K
Yoshikawa, T
Asano, Y
Krause, PR
Citation: T. Argaw et al., Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates, J INFEC DIS, 181(3), 2000, pp. 1153-1157
Authors:
Krause, PR
Straus, SE
Citation: Pr. Krause et Se. Straus, Herpesvirus vaccines - Development, controversies, and applications, INF DIS CL, 13(1), 1999, pp. 61
Authors:
Suzuki, K
Mori, A
Ishii, KJ
Saito, J
Singer, DS
Klinman, DM
Krause, PR
Kohn, LD
Citation: K. Suzuki et al., Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides, P NAS US, 96(5), 1999, pp. 2285-2290
Authors:
Cohen, JI
Brunell, PA
Straus, SE
Krause, PR
Citation: Ji. Cohen et al., Recent advances in varicella-zoster virus infection, ANN INT MED, 130(11), 1999, pp. 922-932
Authors:
Krause, PR
Lewis, AM
Citation: Pr. Krause et Am. Lewis, Safety of viral DNA in biological products, BIOLOGICALS, 26(4), 1998, pp. 317-320
Risultati:
1-15
|